HQL vs HYI

TeklaLife Sciences Investors vs Western Asset High Yield Define — Valuation Comparison 2026

HQL

Asset Management
TeklaLife Sciences Investors
Quality
1.9
out of 10
Value Trap
Price
$17.67
Last close
Models
8/13
Active
VS

HYI

Asset Management
Western Asset High Yield Define
Quality
1.7
out of 10
Value Trap
Price
$10.61
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType HQL Fair ValueHQL Upside HYI Fair ValueHYI Upside
Bayesian DCF Intrinsic $4.68 -73.5% $2.81 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $71.50 +307.4% $9.97 -6.1%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for HQL vs HYI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HQL vs HYI — Which Stock Is More Undervalued?

HQL scores higher with a 1.9/10 quality rating vs HYI's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing TeklaLife Sciences Investors (HQL) and Western Asset High Yield Define (HYI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HQL currently trades at $17.67 with a QOC of 1.9/10, while HYI trades at $10.61 with a QOC of 1.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).